07.22.21
Rank: #26 (Last year: n/a)
$3.64 Billion
Prior Fiscal: $2.85 Billion
Percentage Change: +27.7%
No. of Employees: 10,818
Global Headquarters: Gothenburg, Sweden
KEY EXECUTIVES:
Mattias Perjos, President & CEO
Lars Sandström, CFO
Stéphane Le Roy, President, Surgical Workflows
Jens Viebke, President, Acute Care Therapies
Lena Hagman, EVP, Quality Regulatory Compliance
Harald Castler, President, Life Science
Getinge has been removed from this annual MPO list for a couple of years. Sales have remained positive, but other firms experienced greater growth and bypassed it. The conversion from Swedish Krona to U.S. currency has not always worked in the firm’s favor either. While it’s exciting to see it return to the list, the primary reason for it is unfortunate—increased ventilator demand due to COVID-19.
In mid-March 2020, Gettinge announced it would temporarily increase its production capacity at its facility in Solna, Sweden, by 60 percent (compared to 2019) in order to help address the rapidly growing demand. Once the pandemic really started exploding, the company said it saw rising need for ventilators, extra corporeal life support (ECLS) equipment, and advanced monitoring for Intensive Care Units (ICUs).
By early April, the company expanded on its goal for ventilator production, committing to producing 26,000 by the end of the year (a 160 percent increase over 2019’s 10,000 units). “We continue to ramp up to be able to respond to the increasing demand from our customers,” explained Elin Frostehav, VP Critical Care at Getinge. “We work closely with our sub-contractors and the ramp up is of course pending availability of supply parts.”
Another variable in its ability to meet its goal was available labor force. As such, the day after the second production increase announcement, Getinge stated it had entered into a partnership with Scania. The agreement, which would run through the end of the year, involved the temporary hire of Scania personnel to support Getinge’s ongoing ramp up of its ventilator production. Scania is a provider of transport solutions with 50,000 employees in about 100 countries. The deal between the two organizations moved approximately 30 people from Scania to Getinge.
Getinge was involved in the fight against COVID-19 in other ways as well. It joined with fellow ventilator manufacturers—Dräger, GE Healthcare, Hamilton Medical, Medtronic, Philips, Vyaire Medical, and Nihon Kohden—to form a Ventilator Training Alliance (VTA) to provided frontline medical providers a centralized repository of ventilator training. The VTA app—powered by learning and readiness platform provider Allego—connected respiratory therapists, nurses, and other medical professionals with ventilator training resources from alliance member companies. The content included instructional how-to videos, manuals, troubleshooting guides, and other ventilator operation expertise critical to treating patients suffering from COVID-19-related respiratory distress. By October 2020, the app had surpassed 60,000 downloads.
Getinge also enabled ventilators in its Servo family to be connected to the Getinge Online platform. The goal was to maximize ventilator uptime and help biomedical equipment service technicians stay safe during the pandemic by being able to solve issues remotely, without having to enter ICUs.
The additional production of and demand for Getinge’s products used in the fight against COVID-19 were, as mentioned, directly responsible for the increased net sales the company saw in 2020. The firm finished the year with SEK 29.8 billion, an organic increase of 14.3 percent over 2019’s SEK 26.6 billion.
Among the business units, Acute Care Therapies enjoyed the largest gain, as it is home to the equipment that was in high demand during the pandemic. The segment saw 32.1 percent organic gain year-over-year, growing from SEK 14.6 billion in 2019 to SEK 18.7 billion in 2020.
Life Science—which includes products and services for pharmaceutical bioprocesses as well as contamination prevention offerings across several industries including medical device manufacturing—saw sales rise 3 percent organically. That translated to SEK 2.49 billion in 2019 to SEK 2.85 billion in 2020.
The third business, Surgical Workflows, offers products and solutions for optimizing the quality, safety, and capacity usage of the sterile supply departments and operating rooms. Given the decrease in elective procedures during the pandemic, a 10.3 percent organic decrease was to be expected. The unit dropped from SEK 9.4 billion to SEK 8.25 billion in Getinge’s most recent fiscal.
For as busy as Getinge was to achieve those increased financial figures in its production of equipment and technologies to battle COVID-19, the firm was also occupied with replenishing innovation for healthcare and getting new products to market that would continue to be required beyond the pandemic.
The Maquet Meera CL, a new OR table that comes with a smart hand control to improve usability, was launched in January 2020. It offers a simplified table base with a mechanical locking system and manual leg movement. The design brings all essential functionalities needed, ideal for hospitals looking for price competitive options.
The firm also launched Torin, a complete OR management software that helps surgical departments advance their surgery planning, execute efficiently on schedule, and continuously improve the utilization of resources in and across collaborating departments. It automatically checks for resource and staff conflicts to avoid double bookings as well as inconvenient and expensive waiting time. Additionally, it provides a business intelligence tool that enables management to identify trends and potential inefficiencies and act accordingly.
In May, Getinge introduced a range of consumables for sterile reprocessing. Getinge Assured Superfast 20 Biological Indicator speeds up the ability of the Central Sterile Supply Department to release loads safely, ensuring sterile instruments can be in the right place at the right time.
The company’s Servo-air mechanical ventilator received 510(k) clearance from the U.S. Food & Drug Administration (FDA). The unit joins Getinge’s Servo family, which is used for intensive care ventilation. Intended for pediatric and adult patients, it includes both Invasive and Non Invasive ventilation modes. Servo-air also features options for High Flow therapy and Servo Compass, which allows lung protective ventilation and makes it easier to follow the ARDSnet protocol.
Seeking to address surgery backlogs created by the pause of elective surgeries due to the pandemic (potentially 30 million cancelled or postponed surgeries worldwide in 2020), Getinge offered Torin OptimalQ. This product is a cloud-based software solution that merges customer waiting list data with Getinge knowledge base information on average procedure duration and best planning practices. Matched with patient scorings and hospital capacities, Torin OptimalQ calculates the best way to prioritize the surgery schedule per OR, week, or service.
The company also gained FDA clearance for its Flow-e and Flow-c Anesthesia Systems. These units offer personalized anesthesia delivery for even the most challenging patients, from neonates and pediatric to the morbidly obese.
Getinge offered a larger diameter size of its Advanta V12 balloon expandable covered stent. The stent has been shown to consistently improve patient outcomes by restoring iliac patency, reducing restenosis and re-intervention rates, improving ankle brachial index, and sustaining symptom relief.
The firm also provided the Solsus 66, a versatile, intuitive, and easy-to-use steam sterilizer. The sustainable and energy-efficient sterilizer can be used for general purpose steam sterilization of surgical instruments, textiles, and hospital utensils with a temperature range of 121°C to 134°C.
To provide continuous and noninvasive hemodynamic insights to reduce the risk of severe complications for patients with low blood pressure, Getinge launched the NICCI. With dynamic parameters like cardiac index, stroke volume variation, and pulse pressure variation, NICCI guides individual treatment decisions. It won a Red Dot Award in 2020 for its design.
Getinge’s OR Integration solution Tegris impacts hospitals by improving efficiencies in the operating room, reducing costs, and lightening the administrative burden. Over the years, the Tegris software has evolved significantly to meet customer requirements and emerging trends. With the latest release in 2020, Tegris comes with a brand-new generation hardware platform that is fully dedicated to Video-over-IP and supports 4K ultra-high-definition routing and recording.
The organization also introduced a new range of racks to fit inside the stainless steel DPTE Beta Containers, which are designed for efficient loading and unloading into a sterile zone. The racks stabilize items inside the containers while they are transferred and sterilized. The reusable DPTE Beta Containers are engineered for steam sterilization processes.
Like so many of its peers, Getinge also grew through acquisition in 2020. Shortly after ringing in the new year, the company completed its acquisition of Applikon Biotechnology B.V. The deal was reported to be SEK 840 million (approximately 80 million euros) for 100 percent of the company’s shares. In addition, a maximum earn out of approximately SEK 630 million can be paid out in 2021-2022 if agreed earnings performance is achieved. Applikon develops and supplies advanced bioreactor systems for the research and production of vaccines and antibodies in the biopharmaceutical industry, as well as enzymes and bio-plastics for industrial biotechnology.
At the other end of the calendar, in November 2020, Getinge announced it had purchased Quadralene for SEK 75 million. Quadralene is a U.K.-based company founded in 1930 that designs, commercializes, manufactures, and delivers decontamination products globally. Approximately 75 percent of its revenue comes from the healthcare and dental sector and Getinge was its largest customer, accounting for 43 percent of Quadralene’s revenue.
$3.64 Billion
Prior Fiscal: $2.85 Billion
Percentage Change: +27.7%
No. of Employees: 10,818
Global Headquarters: Gothenburg, Sweden
KEY EXECUTIVES:
Mattias Perjos, President & CEO
Lars Sandström, CFO
Stéphane Le Roy, President, Surgical Workflows
Jens Viebke, President, Acute Care Therapies
Lena Hagman, EVP, Quality Regulatory Compliance
Harald Castler, President, Life Science
Getinge has been removed from this annual MPO list for a couple of years. Sales have remained positive, but other firms experienced greater growth and bypassed it. The conversion from Swedish Krona to U.S. currency has not always worked in the firm’s favor either. While it’s exciting to see it return to the list, the primary reason for it is unfortunate—increased ventilator demand due to COVID-19.
In mid-March 2020, Gettinge announced it would temporarily increase its production capacity at its facility in Solna, Sweden, by 60 percent (compared to 2019) in order to help address the rapidly growing demand. Once the pandemic really started exploding, the company said it saw rising need for ventilators, extra corporeal life support (ECLS) equipment, and advanced monitoring for Intensive Care Units (ICUs).
By early April, the company expanded on its goal for ventilator production, committing to producing 26,000 by the end of the year (a 160 percent increase over 2019’s 10,000 units). “We continue to ramp up to be able to respond to the increasing demand from our customers,” explained Elin Frostehav, VP Critical Care at Getinge. “We work closely with our sub-contractors and the ramp up is of course pending availability of supply parts.”
Another variable in its ability to meet its goal was available labor force. As such, the day after the second production increase announcement, Getinge stated it had entered into a partnership with Scania. The agreement, which would run through the end of the year, involved the temporary hire of Scania personnel to support Getinge’s ongoing ramp up of its ventilator production. Scania is a provider of transport solutions with 50,000 employees in about 100 countries. The deal between the two organizations moved approximately 30 people from Scania to Getinge.
Getinge was involved in the fight against COVID-19 in other ways as well. It joined with fellow ventilator manufacturers—Dräger, GE Healthcare, Hamilton Medical, Medtronic, Philips, Vyaire Medical, and Nihon Kohden—to form a Ventilator Training Alliance (VTA) to provided frontline medical providers a centralized repository of ventilator training. The VTA app—powered by learning and readiness platform provider Allego—connected respiratory therapists, nurses, and other medical professionals with ventilator training resources from alliance member companies. The content included instructional how-to videos, manuals, troubleshooting guides, and other ventilator operation expertise critical to treating patients suffering from COVID-19-related respiratory distress. By October 2020, the app had surpassed 60,000 downloads.
Getinge also enabled ventilators in its Servo family to be connected to the Getinge Online platform. The goal was to maximize ventilator uptime and help biomedical equipment service technicians stay safe during the pandemic by being able to solve issues remotely, without having to enter ICUs.
The additional production of and demand for Getinge’s products used in the fight against COVID-19 were, as mentioned, directly responsible for the increased net sales the company saw in 2020. The firm finished the year with SEK 29.8 billion, an organic increase of 14.3 percent over 2019’s SEK 26.6 billion.
Among the business units, Acute Care Therapies enjoyed the largest gain, as it is home to the equipment that was in high demand during the pandemic. The segment saw 32.1 percent organic gain year-over-year, growing from SEK 14.6 billion in 2019 to SEK 18.7 billion in 2020.
Life Science—which includes products and services for pharmaceutical bioprocesses as well as contamination prevention offerings across several industries including medical device manufacturing—saw sales rise 3 percent organically. That translated to SEK 2.49 billion in 2019 to SEK 2.85 billion in 2020.
The third business, Surgical Workflows, offers products and solutions for optimizing the quality, safety, and capacity usage of the sterile supply departments and operating rooms. Given the decrease in elective procedures during the pandemic, a 10.3 percent organic decrease was to be expected. The unit dropped from SEK 9.4 billion to SEK 8.25 billion in Getinge’s most recent fiscal.
For as busy as Getinge was to achieve those increased financial figures in its production of equipment and technologies to battle COVID-19, the firm was also occupied with replenishing innovation for healthcare and getting new products to market that would continue to be required beyond the pandemic.
The Maquet Meera CL, a new OR table that comes with a smart hand control to improve usability, was launched in January 2020. It offers a simplified table base with a mechanical locking system and manual leg movement. The design brings all essential functionalities needed, ideal for hospitals looking for price competitive options.
The firm also launched Torin, a complete OR management software that helps surgical departments advance their surgery planning, execute efficiently on schedule, and continuously improve the utilization of resources in and across collaborating departments. It automatically checks for resource and staff conflicts to avoid double bookings as well as inconvenient and expensive waiting time. Additionally, it provides a business intelligence tool that enables management to identify trends and potential inefficiencies and act accordingly.
In May, Getinge introduced a range of consumables for sterile reprocessing. Getinge Assured Superfast 20 Biological Indicator speeds up the ability of the Central Sterile Supply Department to release loads safely, ensuring sterile instruments can be in the right place at the right time.
The company’s Servo-air mechanical ventilator received 510(k) clearance from the U.S. Food & Drug Administration (FDA). The unit joins Getinge’s Servo family, which is used for intensive care ventilation. Intended for pediatric and adult patients, it includes both Invasive and Non Invasive ventilation modes. Servo-air also features options for High Flow therapy and Servo Compass, which allows lung protective ventilation and makes it easier to follow the ARDSnet protocol.
Seeking to address surgery backlogs created by the pause of elective surgeries due to the pandemic (potentially 30 million cancelled or postponed surgeries worldwide in 2020), Getinge offered Torin OptimalQ. This product is a cloud-based software solution that merges customer waiting list data with Getinge knowledge base information on average procedure duration and best planning practices. Matched with patient scorings and hospital capacities, Torin OptimalQ calculates the best way to prioritize the surgery schedule per OR, week, or service.
The company also gained FDA clearance for its Flow-e and Flow-c Anesthesia Systems. These units offer personalized anesthesia delivery for even the most challenging patients, from neonates and pediatric to the morbidly obese.
Getinge offered a larger diameter size of its Advanta V12 balloon expandable covered stent. The stent has been shown to consistently improve patient outcomes by restoring iliac patency, reducing restenosis and re-intervention rates, improving ankle brachial index, and sustaining symptom relief.
The firm also provided the Solsus 66, a versatile, intuitive, and easy-to-use steam sterilizer. The sustainable and energy-efficient sterilizer can be used for general purpose steam sterilization of surgical instruments, textiles, and hospital utensils with a temperature range of 121°C to 134°C.
To provide continuous and noninvasive hemodynamic insights to reduce the risk of severe complications for patients with low blood pressure, Getinge launched the NICCI. With dynamic parameters like cardiac index, stroke volume variation, and pulse pressure variation, NICCI guides individual treatment decisions. It won a Red Dot Award in 2020 for its design.
Getinge’s OR Integration solution Tegris impacts hospitals by improving efficiencies in the operating room, reducing costs, and lightening the administrative burden. Over the years, the Tegris software has evolved significantly to meet customer requirements and emerging trends. With the latest release in 2020, Tegris comes with a brand-new generation hardware platform that is fully dedicated to Video-over-IP and supports 4K ultra-high-definition routing and recording.
The organization also introduced a new range of racks to fit inside the stainless steel DPTE Beta Containers, which are designed for efficient loading and unloading into a sterile zone. The racks stabilize items inside the containers while they are transferred and sterilized. The reusable DPTE Beta Containers are engineered for steam sterilization processes.
Like so many of its peers, Getinge also grew through acquisition in 2020. Shortly after ringing in the new year, the company completed its acquisition of Applikon Biotechnology B.V. The deal was reported to be SEK 840 million (approximately 80 million euros) for 100 percent of the company’s shares. In addition, a maximum earn out of approximately SEK 630 million can be paid out in 2021-2022 if agreed earnings performance is achieved. Applikon develops and supplies advanced bioreactor systems for the research and production of vaccines and antibodies in the biopharmaceutical industry, as well as enzymes and bio-plastics for industrial biotechnology.
At the other end of the calendar, in November 2020, Getinge announced it had purchased Quadralene for SEK 75 million. Quadralene is a U.K.-based company founded in 1930 that designs, commercializes, manufactures, and delivers decontamination products globally. Approximately 75 percent of its revenue comes from the healthcare and dental sector and Getinge was its largest customer, accounting for 43 percent of Quadralene’s revenue.